A migraine prophylaxis educational intervention in a Medicaid population

Headache

Volumn 48, Issue 2, 2008, Pages 267-271

  Owens, Christopher ^a   Pugmire, Brooke ^a   Owens, Kimball ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Drug utilization review; Migraine headache; Prophylaxis

Indexed keywords

ALMOTRIPTAN; ELETRIPTAN; FROVATRIPTAN; NARATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ARTICLE; DRUG UTILIZATION; HEALTH EDUCATION; HEALTH PERSONNEL ATTITUDE; HUMAN; MEDICAID; MIGRAINE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS;

DRUG UTILIZATION REVIEW; FEMALE; HUMANS; IDAHO; MALE; MEDICAID; MIGRAINE DISORDERS; PATIENT EDUCATION AS TOPIC; RETROSPECTIVE STUDIES; SEROTONIN AGENTS; TRYPTAMINES; UNITED STATES;

EID: 38749120602     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.01012.x     Document Type: Article

References (11)

1. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000 55 : 754 762.
2. Lipton RB, Stewart WF, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: Results from the American Migraine Study II. Headache. 2001 41 : 638 645.
3. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.
4. Ramadan NM, Silbertstein SD, Freitag FG, Gilbert TT, Frishberg BM Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management for Prevention of Migraine. http://www.aan.com/ professionals/practice/guideline (accessed July 10, 2006).
5. Silberstein SD, Goadsby PJ. Migraine: Preventive treatment. Cephalalgia. 2002 22 : 491 512.
6. Etemad LR, Yang W, Globe D, Barlev A, Johnson KA. Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis. J Manag Care Pharm. 2005 11 : 137 144.
7. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventative treatment for migraine in the United States: Results from the American migraine prevalence and prevention study. Headache. 2007 47 : 355 363.
8. Silberstein SD, Feliu AL, Rupnow MF, Blount AC, Boccuzzi SJ. Topiramate in migraine prophylaxis: Long-term impact on resource utilization and cost. Headache. 2007 47 : 500 510.
9. Snow V, Weiss K, Wall EM, Mottur-Pilson C. American Academy of Family Physicians, American College of Physicians, American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002 137 : 840 849.
10. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006 73 : 72 78.
11. Buchanan TM, Ramadan NM. Prophylactic pharmacotherapy for migraine headaches. Semin Neurol. 2006 26 : 188 198.